PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.080
+0.020 (1.89%)
Feb 18, 2026, 4:00 PM EST - Market closed
PMV Pharmaceuticals Market Cap
PMV Pharmaceuticals has a market cap or net worth of $57.47 million as of February 18, 2026. Its market cap has decreased by -21.79% in one year.
Market Cap
57.47M
Enterprise Value
-71.38M
1-Year Change
-21.79%
Ranking
Category
Stock Price
$1.08
Market Cap Chart
Since the IPO on September 25, 2020, PMV Pharmaceuticals's market cap has decreased from $1.61B to $57.47M, a decrease of -96.44%. That is a compound annual growth rate of -46.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 56.40M | -15.20% |
| Dec 31, 2025 | 66.51M | -14.88% |
| Dec 31, 2024 | 78.14M | -50.73% |
| Dec 29, 2023 | 158.59M | -60.08% |
| Dec 30, 2022 | 397.29M | -62.10% |
| Dec 31, 2021 | 1.05B | -61.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fractyl Health | 64.17M |
| Annovis Bio | 62.81M |
| ImmuCell | 59.52M |
| Mereo BioPharma Group | 59.18M |
| InflaRx | 58.25M |
| Tevogen Bio Holdings | 56.43M |
| Grace Therapeutics | 55.86M |
| Radiopharm Theranostics | 55.14M |